Biohaven (BHVN) Prepaid Assets (2021 - 2026)
Biohaven (BHVN) posted Prepaid Assets of $34.7 million for Q1 2026, down 26.27% sequentially from $47.0 million in Q4 2025, and up 858.18% YoY from $3.6 million in Q1 2025.
Analysis
Biohaven (BHVN) Prepaid Assets (2021 - 2026) Analysis & Trends
Biohaven has reported Prepaid Assets for 6 years, with the latest figure at $34.7 million in Q1 2026.
- Quarterly Prepaid Assets rose 858.18% year-over-year to $34.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.7 million (up 858.18% YoY) and the FY2025 annual result came in at $47.0 million, down 4.77% from the prior year.
- Prepaid Assets eased to $34.7 million in Q1 2026 per BHVN's latest filing, from $47.0 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $61.5 million in Q2 2025 and troughed at $1.2 million in Q3 2024.
- A 5-year average of $28.7 million and a median of $24.7 million in 2023 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets soared 887.51% in 2022, then slumped 96.47% in 2024.
- Over 5 years, Prepaid Assets stood at $20.9 million in 2022, then surged by 68.26% to $35.2 million in 2023, then surged by 40.11% to $49.4 million in 2024, then fell by 4.77% to $47.0 million in 2025, then decreased by 26.27% to $34.7 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $34.7 million, $47.0 million, and $8.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Biohaven | 2.37 Bn | 2.10 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.04 Mn |
| Mar 31, 2026 | 34.67 Mn |
| Dec 31, 2025 | 47.02 Mn |
| Sep 30, 2025 | 54.98 Mn |
| Jun 30, 2025 | 61.49 Mn |
| Mar 31, 2025 | 56.39 Mn |
| Dec 31, 2024 | 49.38 Mn |
| Sep 30, 2024 | 55.17 Mn |
| Jun 30, 2024 | 59.53 Mn |
| Mar 31, 2024 | 46.21 Mn |
| Dec 31, 2023 | 35.24 Mn |
| Sep 30, 2023 | 33.94 Mn |
| Jun 30, 2023 | 27.65 Mn |
| Mar 31, 2023 | 26.40 Mn |
| Dec 31, 2022 | 20.95 Mn |
| Sep 30, 2022 | 17.91 Mn |
| Dec 31, 2021 | 6.73 Mn |